Publications by authors named "Eftychia Psarelli"

Claim this Profile
A
A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma.
Joseph J Sacco, Richard Jackson, Pippa Corrie, Sarah Danson, T R Jeffry Evans, Eftychia Psarelli

Eur J Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies.
Daniela Braconi, Michela Geminiani, Eftychia Eirini Psarelli, Daniela Giustarini, Barbara Marzocchi

Cells· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-PIE) trial: study protocol for a feasibility randomised controlled trial.
Zainab L Rai, Veronica Ranieri, Daniel H Palmer, Peter Littler, Pauleh Ghaneh, Eftychia Eirini Psarelli

BMJ Open· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes.
Lucy Oldfield, Anthony Evans, Rohith Gopala Rao, Claire Jenkinson, Tejpal Purewal, Eftychia E Psarelli

EBioMedicine· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial.
Lakshminarayan R Ranganath, Eftychia Eirini Psarelli, Jean-Baptiste Arnoux, Daniela Braconi, Michael Briggs

Lancet Diabetes Endocrinol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of FDG PET/CT volumetric parameters in the survival prediction of patients with pancreatic cancer.
Eyas Mohamed, Alexander Needham, Eftychia Psarelli, Melvyn Carroll, Sobhan Vinjamuri

Eur J Surg Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria.
Lakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, Milad Khedr, Andrew S Davison, Eftychia E Psarelli

J Inherit Metab Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The nutritional status of people with alkaptonuria: An exploratory analysis suggests a protein/energy dilemma.
Shirley Judd, Milad Khedr, Anna M Milan, Andrew S Davison, Andrew T Hughes, Eftychia E Psarelli

JIMD Rep· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of sorafenib benefit in patients with hepatocellular carcinoma.
Richard Jackson, Eftychia Psarelli, Sarah Berhane, Philip J Johnson

J Hepatol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond ESPAC-4: better surgery and systemic therapy.
Eftychia E Psarelli, Richard Jackson, John P Neoptolemos, Daniel H Palmer, Paula Ghaneh

Lancet· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.
John P Neoptolemos, Daniel H Palmer, Paula Ghaneh, Eftychia E Psarelli, Juan W Valle

Lancet· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment.
Lakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, John J Dutton, Richard Fitzgerald, Eftychia E Psarelli

Ann Rheum Dis· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Is the Best Way to Identify Malignant Transformation Within Pancreatic IPMN: A Systematic Review and Meta-Analyses.
Asma Sultana, Richard Jackson, Gilbert Tim, Emma Bostock, Eftychia E Psarelli

Clin Transl Gastroenterol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colonoscopy performance is stable during the course of an extended three-session working day.
Sreedhar Subramanian, Eftychia E Psarelli, Paul Collins, Neil Haslam, Paul O'Toole

Endosc Int Open· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship Between Serum Concentrations of Nitisinone and Its Effect on Homogentisic Acid and Tyrosine in Patients with Alkaptonuria.
Birgitta Olsson, Trevor F Cox, Eftychia E Psarelli, Johan Szamosi, Andrew T Hughes

JIMD Rep· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nitisinone Arrests but Does Not Reverse Ochronosis in Alkaptonuric Mice.
Craig M Keenan, Andrew J Preston, Hazel Sutherland, Peter J Wilson, Eftychia E Psarelli

JIMD Rep· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced recovery in the resection of colorectal liver metastases.
Declan F J Dunne, Vincent S Yip, Robert P Jones, Ewan A McChesney, Daniel T Lythgoe, Eftychia E Psarelli

J Surg Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis